Researcher Leads Development of Urine Test for Prostate Cancer Detection
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Prostate |
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Aug 2, 2023 | Sepsis |
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Prostate |
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.
Read MorePosted by Andy Lundin | Jul 28, 2023 | Cancer |
A team of scientists developed a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).
Read MorePosted by Andy Lundin | Jul 25, 2023 | Cancer |
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read More